Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

Meeting at the AID Association, one of the organisations working in Yemen to support people living with HIV. Photograph by Anna Surinyach
Feature story
Feature story |
14 June 2013
HIV/AIDS

HIV/AIDS in Yemen: Fighting discrimination

6 min
Feature story
Feature story |
23 April 2013
Intellectual property and trade Research and development Vaccines

Animations: High prices & inappropriate tools prevent MSF from reaching more kids with vaccines

Vaccination during a mobile clinic. Photograph by Ben Milpas
Feature story
Feature story |
22 April 2013
Intellectual property and trade Vaccines

About the "Dear GAVI" Campaign

2 min
Feature story |
03 April 2013

MSF restates its anger and condemnation over the abduction of its two colleagues in Dadaab

Feature story |
26 March 2013
HIV/AIDS Intellectual property and trade
India

Update: Verdict in Novartis vs India case on patents and access to medicines due Monday 1 April

Feature story |
15 March 2013
Intellectual property and trade Tropical & neglected diseases
India

India: MSF Joins Bihar State in Observing Annual Kala Azar Day

3 min
MSF Dr. Christoph Hoehn and nurse Gulru Nobodieva examine a nine-month old baby in Dushanbe, Tajikistan. Photograph by Christoph Hoehn
Feature story
Feature story |
12 March 2013
Intellectual property and trade Tuberculosis
Tajikistan

Tajikistan: MSF treats its youngest-ever patient for multidrug-resistant TB

4 min
Vladimir Shalashniy, Coordinator for MSF’s post-release activities, is checking up on a 31-year old patient who is staying at the Artyomovsk TB dispensary. Photograph by Niklas Bergstrand
Feature story
Feature story |
07 March 2013
HIV/AIDS Tuberculosis
Ukraine

Ukraine: Curbing the MDR-TB Epidemic in Prisons

5 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury